| 19th Oct 2017 7:00 am |
RNS |
Commencement of dosing in PQ Grass Phase II Trial |
| 12th Oct 2017 5:39 pm |
RNS |
Holding(s) in Company |
| 12th Oct 2017 2:55 pm |
RNS |
Director/PDMR Shareholding |
| 10th Oct 2017 7:15 am |
RNS |
Hardman Research: Continuing to gain market share |
| 28th Sep 2017 7:00 am |
RNS |
Preliminary Results |
| 18th Sep 2017 7:00 am |
RNS |
Approval for PQ Grass Phase II trial |
| 11th Sep 2017 7:00 am |
RNS |
Expansion of Clinical Development and R&D teams |
| 15th Aug 2017 7:00 am |
RNS |
Notice of Results |
| 18th Jul 2017 7:00 am |
RNS |
Trading Update |
| 6th Jul 2017 7:00 am |
RNS |
Publication of adjuvant studies in journals |
| 27th Jun 2017 7:00 am |
RNS |
Investor and analyst site visits |
| 19th Jun 2017 7:00 am |
RNS |
Satellite Symposium at EAACI 2017 |
| 6th Jun 2017 7:00 am |
RNS |
Directorate changes |
| 2nd Jun 2017 12:55 pm |
RNS |
Holding(s) in Company |
| 13th Apr 2017 7:00 am |
RNS |
Issue of Equity |
| 5th Apr 2017 7:15 am |
RNS |
Hardman Research: Development across portfolio |
| 29th Mar 2017 7:00 am |
RNS |
Interim Results for six months ended 31 Dec 2016 |
| 16th Mar 2017 7:00 am |
RNS |
First Patient in Pivotal Phase III Birch Study |
| 9th Mar 2017 7:00 am |
RNS |
Notice of Interim Results |
| 14th Feb 2017 7:00 am |
RNS |
House Dust Mite Allergy Vaccine Gains CTA Approval |
| 8th Feb 2017 7:00 am |
RNS |
Directorate Change |
| 1st Feb 2017 7:00 am |
RNS |
Positive Efficacy & Safety Data in Peanut Vaccine |
| 20th Jan 2017 7:15 am |
RNS |
Hardman Research: Investment driving market share |
| 19th Jan 2017 7:00 am |
RNS |
Trading Update |
| 30th Dec 2016 2:31 pm |
RNS |
Grant of Awards |
| 24th Nov 2016 5:23 pm |
RNS |
Result of AGM |
| 2nd Nov 2016 7:00 am |
RNS |
EU Patent Office grants patent for MCT |
| 27th Oct 2016 1:10 pm |
RNS |
Issue of equity in respect of exercise of options |
| 24th Oct 2016 1:35 pm |
RNS |
Annual Report and Accounts |
| 10th Oct 2016 7:00 am |
RNS |
New data from novel adjuvant system |
| 3rd Oct 2016 11:28 am |
RNS |
Issue of equity in respect of exercise of options |
| 29th Sep 2016 12:40 pm |
RNS |
Director/PDMR Shareholding |
| 28th Sep 2016 7:00 am |
RNS |
Director/PDMR Shareholding |
| 26th Sep 2016 11:59 am |
RNS |
Director/PDMR Shareholding |
| 26th Sep 2016 10:46 am |
RNS |
Hardman Research: Performance drives market share |
| 26th Sep 2016 7:00 am |
RNS |
Allergy Therapeutics Preliminary Results |
| 20th Sep 2016 4:58 pm |
RNS |
Issue of equity in respect of exercise of options |
| 5th Sep 2016 7:00 am |
RNS |
Notice of Preliminary Results |
| 13th Jul 2016 7:00 am |
RNS |
Trading Update |
| 8th Jul 2016 7:00 am |
RNS |
Results of mite immunotherapy Acarovac PlusT |
